Early results indicate that Decoy20 causes expected, transient immune-related side effects and demonstrates preliminary efficacy with stable disease observed in patients post-treatment. The trial continues to assess safety, tolerability, and immune activation, supporting the hypothesis of beneficial transient immune stimulation by Decoy20.
Not PCa related: bacteria based immun... - Advanced Prostate...
Not PCa related: bacteria based immune therapy
Written by
Maxone73
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
PCa/Treatments and Immune System
I am Stage IV with some metastases in lung and bone, currently on Lupron, Zytiga, and Prednisone...
Anti PD1 immune therapy
Has anyone had any experience with anti PD1 immune therapy? How were the side effects, especially...
Current status of immune therapy
What is the status of immune therapy for treatment of prostate caner? Several years ago it was...
Oncolytic Virus Therapy for Pca
I understand that there is research being conducted on the use of modified adenoviruses for use as...
The interaction between radiation therapy and immunotherapy for PCa.
The following is from Dr. Myers' blurb for what looks to be an interesting topic:
"This issue...
Plant-based diet and Advanced PCa
